About Ibidi
Ibidi is a company based in Planegg (Germany) founded in 2001. Ibidi operates in a competitive market with competitors including Abcam, Stem Cell Technologies, BioLife Solutions, RoosterBio and Shanghai Doning Biotechnology, among others.
- Latest Funding Round$461.1K (USD), Grant
Apr 2020
- Investors
Funding Insights of Ibidi
- Total Rounds 5
- Last Round Grant — $461,104
- First Round $301,267
(Jan 2015)
- Investors Count 1
All 5 funding rounds of Ibidi with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2020 | $461,104 | Grant | – | – | |
| Jan 2020 | $461,104 | Grant | – | – | |
| Aug 2016 | $54,621 | Grant | – | – | |
| Jan 2016 | $54,621 | Grant | – | – | |
| Jan 2015 | $301,267 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in Ibidi
Ibidi has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Ibidi
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Ibidi
7 people are tracked at Ibidi (6 in leadership, 1 in team).
| Name | Role | Group |
|---|---|---|
Roman Zantl | CEO | Leadership |
Ben Schauer | Vice President Of Sales | Leadership |
Susanne Seifert | Head Of Marketing | Leadership |
Iris Hauerwaas | Head Of Human Resources | Leadership |
Jan Schwarz | Head Of Labware & Reagents R&d | Leadership |
Peggy Benisch | Head Of Sales | Leadership |
Julia Schirmer | Technical Marketing Specialist | Team |
Complete people profiles for Ibidi
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Ibidi
3 dated milestones of Ibidi across 19 years, from founding to its latest funding, stage changes and deals.
- Founded Ibidi is founded.
- Funding First funding round of $301K.
- Funding Latest funding round, Grant, of $461K.
Competitors of Ibidi
Ibidi operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Stem Cell Technologies, BioLife Solutions, RoosterBio and Shanghai Doning Biotechnology, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| abcam.com | 1998 | Cambridge, United Kingdom | $78.8M | 405 | Biological reagents and antibodies are developed for life science research. | |
| stemcell.com | 1993 | Vancouver, Canada | $11.92M | 129 | Developer of cell culture media and ancillary reagents for life science research | |
| biolifesolutions.com | 1987 | Bothell, United States | – | 685 | Tissue hypothermic storage and cryopreservation freeze media are developed. | |
| roosterbio.com | 2012 | Frederick, United States | $38.41M | 69 | Developer of human mesenchymal stem cells and extracellular vesicles | |
| duoningbio.com | 2005 | Shanghai, China | $14.88M | – | Serum-free cell culture media is supplied to biopharmaceutical industries. | |
| polyplus-transfection.com | 2001 | Illkirch Graffenstaden, France | $3.23M | – | Transfection Solutions for Healthcare and Life Sciences organizations | |
| origene.com | 1996 | Rockville, United States | $69.55M | 141 | Proteins, antibodies, and molecular tools are manufactured for research applications. | |
| sangon.com | 2003 | Shanghai, China | $300M | – | Research services, reagents, and kits for biotech applications are provided. | |
| arunabio.com | 2017 | Athens, United States | $38.51M | – | Neural exosome platform is developed for neurodegenerative disease therapeutics. | |
| biotangents.co.uk | 2015 | Edinburgh, United Kingdom | $5.62M | 13 | Veterinary diagnostics products are developed for bovine viral diarrhea testing. |
Detailed competitors of Ibidi
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Ibidi
The website of Ibidi (ibidi.com) receives about 72.3K visits a month.
- Monthly visits72.3K
▼ 1.3% vs previous month
Websites whose visitors overlap most with Ibidi. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
glass-bottom-dishes.com | glass-bottom-dishes.com | 100% | – | – | – |
| nanion.de | 98% | 13.2K | #1,841,615 | View details | |
| stoeltingco.com | 90% | 20.9K | #1,185,789 | View details | |
| btxonline.com | 86% | 4.6K | #4,281,571 | View details | |
| arigobio.com | 84% | – | #1,330,300 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Ibidi
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to Ibidi
10 companies that operate in the same segment as Ibidi (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Ibidi
Ibidi was founded in 2001 and raised its 1st funding round 14 years after it was founded.
Ibidi is headquartered in Planegg, Germany. It is registered at Planegg, Bavaria, Germany.
Ibidi was founded in 2001 in Planegg, Germany, within the biotechnology sector focused on cell analysis. Products for cell-based assays and microscopy are developed, including heating and incubation systems, optical O2 measurement systems, 3D live cell imaging through Nanolive, pump systems, cells and reagents for transfection and imaging, and software for image analysis. Services provided encompass custom cell line maintenance, functional cell-based assays, and viral vectors.
Ibidi's top competitors include Abcam, RoosterBio and BioLife Solutions.
Ibidi has 1 investor. Key investors include European Union.